Found: 96
Select item for more details and to access through your institution.
Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of Variable Frequency Stimulation Sacral Neuromodulation for Different Genders: A Chinese Multicentric Prospective Clinical Study.
- Published in:
- Neurourology & Urodynamics, 2024, v. 43, n. 8, p. 1793, doi. 10.1002/nau.25581
- By:
- Publication type:
- Article
Overexpression of PIM‐1 is a potential biomarker in prostate carcinomaYong Xu and Tong Zhang contributed equally to this work.
- Published in:
- Journal of Surgical Oncology, 2005, v. 92, n. 4, p. 326, doi. 10.1002/jso.20325
- By:
- Publication type:
- Article
Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
- Published in:
- Clinical & Experimental Medicine, 2018, v. 18, n. 2, p. 165, doi. 10.1007/s10238-018-0488-3
- By:
- Publication type:
- Article
Depletion of androgen receptor (AR) in mesenchymal stem cells (MSCs) inhibits induction of CD4+CD25+FOX3+ regulatory T (Treg) cells via androgen TGF-β interaction.
- Published in:
- Journal of Applied Biomedicine, 2015, v. 13, n. 4, p. 263, doi. 10.1016/j.jab.2015.06.002
- By:
- Publication type:
- Article
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
- Published in:
- NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-00137-0
- By:
- Publication type:
- Article
Circ_0001686 Promotes Prostate Cancer Progression by Up-Regulating SMAD3/TGFBR2 via miR-411-5p.
- Published in:
- World Journal of Men's Health, 2022, v. 40, n. 1, p. 149, doi. 10.5534/wjmh.200204
- By:
- Publication type:
- Article
KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
- Published in:
- Shock & Vibration, 2019, p. 1, doi. 10.1155/2019/4863182
- By:
- Publication type:
- Article
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
- Published in:
- Nucleic Acids Research, 2019, v. 47, n. 8, p. 4211, doi. 10.1093/nar/gkz108
- By:
- Publication type:
- Article
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 2, p. 999, doi. 10.1093/nar/gkt921
- By:
- Publication type:
- Article
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15396-5
- By:
- Publication type:
- Article
Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy.
- Published in:
- BMC Surgery, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12893-024-02487-z
- By:
- Publication type:
- Article
Bronchogenic cysts in retroperitoneal region.
- Published in:
- 2013
- By:
- Publication type:
- Report
Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/4782730
- By:
- Publication type:
- Article
KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/4863182
- By:
- Publication type:
- Article
Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.778850
- By:
- Publication type:
- Article
Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.886983
- By:
- Publication type:
- Article
Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.809794
- By:
- Publication type:
- Article
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Post-transcriptional modification of m<sup>6</sup>A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 4, p. 1, doi. 10.1038/s41419-023-05773-5
- By:
- Publication type:
- Article
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 3, p. 1, doi. 10.1038/s41419-023-05742-y
- By:
- Publication type:
- Article
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 11, p. 1, doi. 10.1038/s41419-022-05366-8
- By:
- Publication type:
- Article
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-04979-3
- By:
- Publication type:
- Article
The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 9, p. 1, doi. 10.1038/s41419-020-02932-w
- By:
- Publication type:
- Article
Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 5, p. 1, doi. 10.1038/s41419-020-2486-0
- By:
- Publication type:
- Article
Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 2, p. 1, doi. 10.1038/s41419-018-1048-1
- By:
- Publication type:
- Article
G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0504-2
- By:
- Publication type:
- Article
Efficacy of povidone-iodine against accidental tumor incision during nephron-sparing surgery: experimental study in patients with renal cell carcinoma.
- Published in:
- Journal of International Medical Research, 2019, v. 47, n. 10, p. 4993, doi. 10.1177/0300060519874155
- By:
- Publication type:
- Article
DNA‐repair status should be assessed in treatment‐emergent neuroendocrine prostate cancer before platinum‐based therapy.
- Published in:
- Prostate, 2022, v. 82, n. 4, p. 464, doi. 10.1002/pros.24292
- By:
- Publication type:
- Article
Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
- Published in:
- Prostate, 2015, v. 75, n. 14, p. 1632, doi. 10.1002/pros.23044
- By:
- Publication type:
- Article
Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells.
- Published in:
- Prostate, 2013, v. 73, n. 12, p. 1306, doi. 10.1002/pros.22676
- By:
- Publication type:
- Article
Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts.
- Published in:
- Prostate, 2012, v. 72, n. 4, p. 437, doi. 10.1002/pros.21445
- By:
- Publication type:
- Article
Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells.
- Published in:
- Prostate, 2011, v. 71, n. 5, p. 517, doi. 10.1002/pros.21264
- By:
- Publication type:
- Article
The Expression of Neurotensin in Animal Model of Androgen Independent Prostate Cancer.
- Published in:
- Tianjin Medical Journal, 2014, v. 42, n. 9, p. 878, doi. 10.3969/j.issn.0253-9896.2014.09.008
- By:
- Publication type:
- Article
Heat-shock protein 60 of Porphyromonas gingivalis may induce dysfunction of human umbilical endothelial cells via regulation of endothelial-nitric oxide synthase and vascular endothelial-cadherin.
- Published in:
- Biomedical Reports, 2016, v. 5, n. 2, p. 243, doi. 10.3892/br.2016.693
- By:
- Publication type:
- Article
Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Drug‐Loaded Bacillus Calmette–Guérin Bacteria for Immuno‐Chemo Combo Therapy in Bladder Cancer.
- Published in:
- Advanced Materials, 2024, v. 36, n. 19, p. 1, doi. 10.1002/adma.202310735
- By:
- Publication type:
- Article
Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 786, doi. 10.3390/vaccines9070786
- By:
- Publication type:
- Article
Increased KIF4A expression is a potential prognostic factor in prostate cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 5, p. 7941, doi. 10.3892/ol.2018.8322
- By:
- Publication type:
- Article
Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4364, doi. 10.3892/ol.2017.6010
- By:
- Publication type:
- Article
Primary renal sinus tumor: Three case reports with a review of the literature.
- Published in:
- Oncology Letters, 2015, v. 9, n. 2, p. 829, doi. 10.3892/ol.2014.2729
- By:
- Publication type:
- Article
Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
- Published in:
- Theranostics, 2021, v. 11, n. 4, p. 1780, doi. 10.7150/thno.51931
- By:
- Publication type:
- Article
[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8602
- By:
- Publication type:
- Article
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 921, doi. 10.3892/or.2021.7920
- By:
- Publication type:
- Article
Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
- Published in:
- Oncology Reports, 2018, v. 40, n. 2, p. 959, doi. 10.3892/or.2018.6476
- By:
- Publication type:
- Article
CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11870-1
- By:
- Publication type:
- Article
Association of the Glutathione S-transferases M1 and T1 polymorphism with male infertility: a meta-analysis.
- Published in:
- Journal of Assisted Reproduction & Genetics, 2013, v. 30, n. 1, p. 131, doi. 10.1007/s10815-012-9907-7
- By:
- Publication type:
- Article
Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma.
- Published in:
- Immunogenetics, 2022, v. 74, n. 3, p. 285, doi. 10.1007/s00251-021-01246-1
- By:
- Publication type:
- Article